Alimta 100 mg Injection
Brand Name: Alimta
Molecule: Pemetrexed
Strength: 100 mg
Quantity: 1 Vial
Form: Injection
Packaging Type: Vial
Manufacturer/Marketed By: Eli Lilly And Company
Country of Origin: India
Please fill in the details below, and we’ll get back to you as soon as possible
Similar Products:
| Image | Product | Manufacturer / Marketed By | Price |
|---|---|---|---|
 | Pemnat 100 mg Injection | Natco Pharma | Ask for Price |
Description
Alimta 100mg Injection contains Pemetrexed, a chemotherapy medicine used to treat non-small cell lung cancer and malignant pleural mesothelioma. It slows cancer cell growth and is administered under oncologist supervision.
Benefits
-
Helps slow tumor growth and disease progression
-
Improves treatment response in eligible lung cancer patients
-
Effective when used alone or in combination therapy
-
Well-established chemotherapy option with proven clinical results
Indications and Usage
Alimta 100mg Injection is indicated for:
-
Non-squamous Non-Small Cell Lung Cancer (NSCLC)
-
Malignant Pleural Mesothelioma
-
May be given alone or with platinum-based chemotherapy like cisplatin
Treatment must be initiated and managed by an oncologist.
How it Works
Pemetrexed blocks folate-dependent enzymes needed for DNA and RNA synthesis. This prevents cancer cells from dividing and multiplying, helping control tumor growth.
Dosage & Administration
-
Dosage based on body surface area (BSA) and clinical condition
-
Given as an intravenous infusion every 3 weeks
-
Requires folic acid, vitamin B12, and corticosteroids before treatment
-
Must be administered by trained healthcare professionals
-
Regular blood tests and kidney function monitoring required
Side Effects
Common side effects:
-
Fatigue or weakness
-
Nausea, vomiting, appetite loss
-
Mouth sores
-
Rash or itching
-
Low blood cell counts (anemia, neutropenia)
Serious side effects (seek medical care):
-
Severe infection or fever
-
Kidney problems
-
Breathing difficulty
-
Severe allergic reaction
-
Unusual bleeding or bruising
Warning and Precaution
-
Not recommended during pregnancy or breastfeeding
-
Avoid use in severe kidney impairment unless advised
-
Monitor blood counts, liver & kidney function routinely
-
Inform doctor about NSAIDs, blood thinners, or other medications
-
Increased risk of infection—report fever or sore throat immediately
-
Maintain proper hydration unless medically restricted
Related Products
Related Posts:
Ruxolitinib Tablets Receive FDA Approval for Hematologic Malignancies
The U.S. Food and Drug Administration (FDA) has approved Ruxolitinib tablets for the treatment of certain hematologic malignancies, marking another
READ MORE »May 18, 2026
Tovorafenib Approved in Europe for Children with BRAF-Altered Low-Grade Glioma
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on May 14, 2026.n n This marks an important
READ MORE »May 14, 2026
FDA Fast-Tracks Plixorafenib for BRAF V600E–Mutated Brain Tumors
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 14, 2026.n n Brain tumors, especially high-grade
READ MORE »April 14, 2026
Only logged in customers who have purchased this product may leave a review.
Reviews
Clear filtersThere are no reviews yet.